These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 31236131)

  • 1. Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease.
    Gao C; Liu L; Zhou Y; Bian Z; Wang S; Wang Y
    Chin Med; 2019; 14():23. PubMed ID: 31236131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric Inflammatory Bowel Disease: Clinical Presentation and Disease Location.
    Aziz DA; Moin M; Majeed A; Sadiq K; Biloo AG
    Pak J Med Sci; 2017; 33(4):793-797. PubMed ID: 29067041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very-early-onset inflammatory bowel disease versus late-onset inflammatory bowel disease in relation to clinical phenotype: A cross-sectional study.
    Mansour HH; Seddek SS; Meguid MEAEL; Eskander AE; Galal ST
    Indian J Gastroenterol; 2023 Apr; 42(2):185-191. PubMed ID: 37166697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
    Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
    Seo JK; Yeon KM; Chi JG
    J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer.
    Cai Y; Zhang L; Zhang Y; Lu R
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456656
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Hou M; Leng Y; Shi Y; Tan Z; Min X
    Am J Chin Med; 2023; 51(6):1501-1526. PubMed ID: 37530507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer.
    Rubin DC; Shaker A; Levin MS
    Front Immunol; 2012; 3():107. PubMed ID: 22586430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease.
    Yang L; Luo H; Tan D; Zhang S; Zhong Z; Wang S; Vong CT; Wang Y
    Phytomedicine; 2021 Nov; 92():153709. PubMed ID: 34560518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Insight into Herbal Bioactives-based Novel Approaches for Chronic Intestinal Inflammatory Disorders Therapy.
    Harwansh RK; Chauhan S; Deshmukh R; Mazumder R
    Curr Pharm Biotechnol; 2024; 25(14):1835-1857. PubMed ID: 38310453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA-GPGE Registry.
    Elonen L; Wölfle L; de Laffolie J; Posovszky C;
    Front Pediatr; 2022; 10():875938. PubMed ID: 35712614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Update on Herbal Products for the Management of Inflammatory Bowel Disease.
    Arya H; Dass R; Chopra B; Kriplani P; Deswal G; Singh Grewal A; Dhingra AK; Kumar S
    Antiinflamm Antiallergy Agents Med Chem; 2023; 22(1):1-9. PubMed ID: 37497699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies.
    Liu P; Gao C; Chen H; Vong CT; Wu X; Tang X; Wang S; Wang Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2798-2818. PubMed ID: 34589398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
    Yang C; Merlin D
    Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.